Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial
Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM‐RS2), attenuates oxidative stress and inflammation, an...
Gespeichert in:
Veröffentlicht in: | Hemodialysis international 2018-10, Vol.22 (4), p.492-500 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 500 |
---|---|
container_issue | 4 |
container_start_page | 492 |
container_title | Hemodialysis international |
container_volume | 22 |
creator | Tayebi Khosroshahi, Hamid Vaziri, Nosratola D. Abedi, Behzad Asl, Bahlol Habibi Ghojazadeh, Morteza Jing, Wanghui Vatankhah, Amir Mansur |
description | Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM‐RS2), attenuates oxidative stress and inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to explore the effect of dietary amylose supplementation in hemodialysis patients.
Methods: Forty‐six stable hemodialysis patients were randomized to receive biscuits containing 20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM‐RS2 or wheat‐flour. Fasting predialysis blood samples obtained before, during and at the end of trial were processed for biomarkers of oxidative stress and inflammation.
Findings: There was no significant difference in baseline clinical or biochemical parameters between the two groups. Serum levels of TNF‐α, IL‐6, and malondialdehyde declined significantly (P |
doi_str_mv | 10.1111/hdi.12653 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2013516076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2013516076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4263-c7825baec8e052a6a3880fa879ee7b0a341c2d64d700d71944c54ce29c30912d3</originalsourceid><addsrcrecordid>eNp1kUtu1TAUhi0EoqUwYAPIw3aQ1s88mFWlcCsVIfEYR772CTHYcbBzgcuIJbAQVsVKOCWFGZblh853Pkv-CXnM2SnHcTY6f8pFreUdcsi1EpVqdHsXz6oTVaOlPiAPSvnAmOCM1ffJgei0FF3LD8nPy2EAu9A00NG_H6mJ-5AK0AzFl8VMC8U125Eeb85f_vr-4_UbcULLbp4DRJgWs_g0UZxbn6LJHyGXG5WfhmBiXKtmcjR99Q5vnwF1qC5I0BFict6EPb5EZ6yirzylhmbsSNF_A0dt8JO3JtAlI_mQ3BtMKPDodj8i755fvr3YVNevXlxdnF9XVolaVrZphd4asC0wLUxtZNuywbRNB9BsmZGKW-Fq5RrGXMM7paxWFkRnJeu4cPKIHK_eOadPOyhLH32xEIKZIO1KLxiXmtesqRE9WVGbUykZhn7OHn9i33PW34TTYzj9n3CQfXKr3W0juH_k3zQQOFuBLz7A_v-mfvPsalX-BujenN0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2013516076</pqid></control><display><type>article</type><title>Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Tayebi Khosroshahi, Hamid ; Vaziri, Nosratola D. ; Abedi, Behzad ; Asl, Bahlol Habibi ; Ghojazadeh, Morteza ; Jing, Wanghui ; Vatankhah, Amir Mansur</creator><creatorcontrib>Tayebi Khosroshahi, Hamid ; Vaziri, Nosratola D. ; Abedi, Behzad ; Asl, Bahlol Habibi ; Ghojazadeh, Morteza ; Jing, Wanghui ; Vatankhah, Amir Mansur</creatorcontrib><description>Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM‐RS2), attenuates oxidative stress and inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to explore the effect of dietary amylose supplementation in hemodialysis patients.
Methods: Forty‐six stable hemodialysis patients were randomized to receive biscuits containing 20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM‐RS2 or wheat‐flour. Fasting predialysis blood samples obtained before, during and at the end of trial were processed for biomarkers of oxidative stress and inflammation.
Findings: There was no significant difference in baseline clinical or biochemical parameters between the two groups. Serum levels of TNF‐α, IL‐6, and malondialdehyde declined significantly (P < 0.05) in the HAM‐RS2‐treated group but remained unchanged in the placebo‐treated group. No significant difference was observed in serum Interleukin‐1β (IL‐1β) and hs‐CRP concentrations and total antioxidant activity between two groups. Serum urea and creatinine concentrations significantly declined and severity of constipation improved in HAM‐RS2‐treated patients (P < 0.05). HAM‐RS2 consumption was well tolerated and did not cause discernible side effects.
Discussion: Administration of HAM‐RS2 for eight weeks significantly reduced levels of inflammatory and oxidative markers in hemodialysis patients confirming the results observed in CKD animals. Long term trials are needed to explore the impact of HAM‐RS2 supplementation on clinical outcomes in end stage renal disease population.</description><identifier>ISSN: 1492-7535</identifier><identifier>EISSN: 1542-4758</identifier><identifier>DOI: 10.1111/hdi.12653</identifier><identifier>PMID: 29532981</identifier><language>eng</language><publisher>Canada</publisher><subject>Amylose - metabolism ; Animals ; Biomarkers - chemistry ; Double-Blind Method ; End stage renal disease ; Female ; hemodialysis ; high maize resistant starch2 ; Humans ; Inflammation - metabolism ; inflammatory marker ; Kidney Failure, Chronic - drug therapy ; Kidney Failure, Chronic - pathology ; Male ; Middle Aged ; oxidative markers ; Oxidative Stress - physiology ; Rats ; Renal Dialysis - methods ; Starch - metabolism</subject><ispartof>Hemodialysis international, 2018-10, Vol.22 (4), p.492-500</ispartof><rights>2018 International Society for Hemodialysis</rights><rights>2018 International Society for Hemodialysis.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4263-c7825baec8e052a6a3880fa879ee7b0a341c2d64d700d71944c54ce29c30912d3</citedby><cites>FETCH-LOGICAL-c4263-c7825baec8e052a6a3880fa879ee7b0a341c2d64d700d71944c54ce29c30912d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhdi.12653$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhdi.12653$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29532981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tayebi Khosroshahi, Hamid</creatorcontrib><creatorcontrib>Vaziri, Nosratola D.</creatorcontrib><creatorcontrib>Abedi, Behzad</creatorcontrib><creatorcontrib>Asl, Bahlol Habibi</creatorcontrib><creatorcontrib>Ghojazadeh, Morteza</creatorcontrib><creatorcontrib>Jing, Wanghui</creatorcontrib><creatorcontrib>Vatankhah, Amir Mansur</creatorcontrib><title>Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial</title><title>Hemodialysis international</title><addtitle>Hemodial Int</addtitle><description>Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM‐RS2), attenuates oxidative stress and inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to explore the effect of dietary amylose supplementation in hemodialysis patients.
Methods: Forty‐six stable hemodialysis patients were randomized to receive biscuits containing 20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM‐RS2 or wheat‐flour. Fasting predialysis blood samples obtained before, during and at the end of trial were processed for biomarkers of oxidative stress and inflammation.
Findings: There was no significant difference in baseline clinical or biochemical parameters between the two groups. Serum levels of TNF‐α, IL‐6, and malondialdehyde declined significantly (P < 0.05) in the HAM‐RS2‐treated group but remained unchanged in the placebo‐treated group. No significant difference was observed in serum Interleukin‐1β (IL‐1β) and hs‐CRP concentrations and total antioxidant activity between two groups. Serum urea and creatinine concentrations significantly declined and severity of constipation improved in HAM‐RS2‐treated patients (P < 0.05). HAM‐RS2 consumption was well tolerated and did not cause discernible side effects.
Discussion: Administration of HAM‐RS2 for eight weeks significantly reduced levels of inflammatory and oxidative markers in hemodialysis patients confirming the results observed in CKD animals. Long term trials are needed to explore the impact of HAM‐RS2 supplementation on clinical outcomes in end stage renal disease population.</description><subject>Amylose - metabolism</subject><subject>Animals</subject><subject>Biomarkers - chemistry</subject><subject>Double-Blind Method</subject><subject>End stage renal disease</subject><subject>Female</subject><subject>hemodialysis</subject><subject>high maize resistant starch2</subject><subject>Humans</subject><subject>Inflammation - metabolism</subject><subject>inflammatory marker</subject><subject>Kidney Failure, Chronic - drug therapy</subject><subject>Kidney Failure, Chronic - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>oxidative markers</subject><subject>Oxidative Stress - physiology</subject><subject>Rats</subject><subject>Renal Dialysis - methods</subject><subject>Starch - metabolism</subject><issn>1492-7535</issn><issn>1542-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtu1TAUhi0EoqUwYAPIw3aQ1s88mFWlcCsVIfEYR772CTHYcbBzgcuIJbAQVsVKOCWFGZblh853Pkv-CXnM2SnHcTY6f8pFreUdcsi1EpVqdHsXz6oTVaOlPiAPSvnAmOCM1ffJgei0FF3LD8nPy2EAu9A00NG_H6mJ-5AK0AzFl8VMC8U125Eeb85f_vr-4_UbcULLbp4DRJgWs_g0UZxbn6LJHyGXG5WfhmBiXKtmcjR99Q5vnwF1qC5I0BFict6EPb5EZ6yirzylhmbsSNF_A0dt8JO3JtAlI_mQ3BtMKPDodj8i755fvr3YVNevXlxdnF9XVolaVrZphd4asC0wLUxtZNuywbRNB9BsmZGKW-Fq5RrGXMM7paxWFkRnJeu4cPKIHK_eOadPOyhLH32xEIKZIO1KLxiXmtesqRE9WVGbUykZhn7OHn9i33PW34TTYzj9n3CQfXKr3W0juH_k3zQQOFuBLz7A_v-mfvPsalX-BujenN0</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Tayebi Khosroshahi, Hamid</creator><creator>Vaziri, Nosratola D.</creator><creator>Abedi, Behzad</creator><creator>Asl, Bahlol Habibi</creator><creator>Ghojazadeh, Morteza</creator><creator>Jing, Wanghui</creator><creator>Vatankhah, Amir Mansur</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201810</creationdate><title>Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial</title><author>Tayebi Khosroshahi, Hamid ; Vaziri, Nosratola D. ; Abedi, Behzad ; Asl, Bahlol Habibi ; Ghojazadeh, Morteza ; Jing, Wanghui ; Vatankhah, Amir Mansur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4263-c7825baec8e052a6a3880fa879ee7b0a341c2d64d700d71944c54ce29c30912d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Amylose - metabolism</topic><topic>Animals</topic><topic>Biomarkers - chemistry</topic><topic>Double-Blind Method</topic><topic>End stage renal disease</topic><topic>Female</topic><topic>hemodialysis</topic><topic>high maize resistant starch2</topic><topic>Humans</topic><topic>Inflammation - metabolism</topic><topic>inflammatory marker</topic><topic>Kidney Failure, Chronic - drug therapy</topic><topic>Kidney Failure, Chronic - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>oxidative markers</topic><topic>Oxidative Stress - physiology</topic><topic>Rats</topic><topic>Renal Dialysis - methods</topic><topic>Starch - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Tayebi Khosroshahi, Hamid</creatorcontrib><creatorcontrib>Vaziri, Nosratola D.</creatorcontrib><creatorcontrib>Abedi, Behzad</creatorcontrib><creatorcontrib>Asl, Bahlol Habibi</creatorcontrib><creatorcontrib>Ghojazadeh, Morteza</creatorcontrib><creatorcontrib>Jing, Wanghui</creatorcontrib><creatorcontrib>Vatankhah, Amir Mansur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hemodialysis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tayebi Khosroshahi, Hamid</au><au>Vaziri, Nosratola D.</au><au>Abedi, Behzad</au><au>Asl, Bahlol Habibi</au><au>Ghojazadeh, Morteza</au><au>Jing, Wanghui</au><au>Vatankhah, Amir Mansur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial</atitle><jtitle>Hemodialysis international</jtitle><addtitle>Hemodial Int</addtitle><date>2018-10</date><risdate>2018</risdate><volume>22</volume><issue>4</issue><spage>492</spage><epage>500</epage><pages>492-500</pages><issn>1492-7535</issn><eissn>1542-4758</eissn><abstract>Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM‐RS2), attenuates oxidative stress and inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to explore the effect of dietary amylose supplementation in hemodialysis patients.
Methods: Forty‐six stable hemodialysis patients were randomized to receive biscuits containing 20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM‐RS2 or wheat‐flour. Fasting predialysis blood samples obtained before, during and at the end of trial were processed for biomarkers of oxidative stress and inflammation.
Findings: There was no significant difference in baseline clinical or biochemical parameters between the two groups. Serum levels of TNF‐α, IL‐6, and malondialdehyde declined significantly (P < 0.05) in the HAM‐RS2‐treated group but remained unchanged in the placebo‐treated group. No significant difference was observed in serum Interleukin‐1β (IL‐1β) and hs‐CRP concentrations and total antioxidant activity between two groups. Serum urea and creatinine concentrations significantly declined and severity of constipation improved in HAM‐RS2‐treated patients (P < 0.05). HAM‐RS2 consumption was well tolerated and did not cause discernible side effects.
Discussion: Administration of HAM‐RS2 for eight weeks significantly reduced levels of inflammatory and oxidative markers in hemodialysis patients confirming the results observed in CKD animals. Long term trials are needed to explore the impact of HAM‐RS2 supplementation on clinical outcomes in end stage renal disease population.</abstract><cop>Canada</cop><pmid>29532981</pmid><doi>10.1111/hdi.12653</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1492-7535 |
ispartof | Hemodialysis international, 2018-10, Vol.22 (4), p.492-500 |
issn | 1492-7535 1542-4758 |
language | eng |
recordid | cdi_proquest_miscellaneous_2013516076 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Amylose - metabolism Animals Biomarkers - chemistry Double-Blind Method End stage renal disease Female hemodialysis high maize resistant starch2 Humans Inflammation - metabolism inflammatory marker Kidney Failure, Chronic - drug therapy Kidney Failure, Chronic - pathology Male Middle Aged oxidative markers Oxidative Stress - physiology Rats Renal Dialysis - methods Starch - metabolism |
title | Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T10%3A48%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20high%20amylose%20resistant%20starch%20(HAM%E2%80%90RS2)%20supplementation%20on%20biomarkers%20of%20inflammation%20and%20oxidative%20stress%20in%20hemodialysis%20patients:%20a%20randomized%20clinical%20trial&rft.jtitle=Hemodialysis%20international&rft.au=Tayebi%20Khosroshahi,%20Hamid&rft.date=2018-10&rft.volume=22&rft.issue=4&rft.spage=492&rft.epage=500&rft.pages=492-500&rft.issn=1492-7535&rft.eissn=1542-4758&rft_id=info:doi/10.1111/hdi.12653&rft_dat=%3Cproquest_cross%3E2013516076%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2013516076&rft_id=info:pmid/29532981&rfr_iscdi=true |